Abstract
Stauntonia hexaphylla (Lardizabalaceae) is an important medicinal plant in Korea, Japan, and China. Its leaves are used to treat many diseases because of their analgesic, sedative, and diuretic effects; however, there are few reports on their chemical constituents and biological activities. This study divided an ethanol extract into dichloromethane (DCM), ethyl acetate (EtOAc), and water fractions. Bioassay-guided fractionation of the ethanol extracts led to the isolation of seven compounds (1–7). To our knowledge, this is the first report of 1–7 from S. hexaphylla. The anti-inflammatory effects were investigated by suppressing cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in Western blots. The ethanol extract (20 µg/mL), DCM fraction (20 µg/mL), and compound 1 (10 µM) decreased COX-2 and iNOS expression significantly in LPS-induced RAW264.7 cells. These results suggest that S. hexaphylla leaves and compound 1 are useful candidates for treating inflammatory and other diseases.
Original language | English |
---|---|
Pages (from-to) | 1852-1855 |
Number of pages | 4 |
Journal | Natural Product Research |
Volume | 35 |
Issue number | 11 |
DOIs | |
State | Published - 2021 |
Keywords
- COX-2
- Lardizabalaceae
- Stauntonia hexaphylla
- anti-inflammatory effects
- iNOS